Distribution of Hepatitis C Risk Factors and HCV Treatment Outcomes among Central Canadian Aboriginal

Table 2

Categorical demographic characteristics and indicators of HCV management, treatment, and outcomes according to Aboriginal status.

Categorical variables	Aboriginal status		value
	Aboriginal ()	Non-Aboriginal ()
Underwent biopsy	44.4	48.9	0.517
Underwent Fibroscan	13.0	15.3	0.64
Initiated HCV antiviral therapy	37.0	40.8	0.574
Use of erythropoietin	0.0	6.4	0.054
Treatment type			0.262
Naive	63.0	60.7
Interferon based	37.0	34.5
DAA IFN	0.0	4.7
Treatment status			0.001
Treatment failure	10.0	13.3
Side effects/adverse event	25.0	21.3
Adherence/substance abuse/lack of follow-up	25.0	4.6
Completed treatment	40.0	60.9
Achieved SVR	56.3	58.9	0.833
Achieved SVR by genotype
G1	60.0	54.3	0.720
G2	0.0	82.6	0.035
G3	75.0	66.4	0.720
G4	—	32.4	—
G5	—	100.0	—
G6	—	77.8	—

The results represent “%”.